Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 11/20 | 0.44 |
| ▸ | CES1 | P23141 | 6/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9698734 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL2679887 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL6939659 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL6932074 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL5960841 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL27737023 | 1.00 | TSHR (0.46) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL981371 | 0.97 | TSHR (0.42) | TSHRFAAHCES1THRBTRPV1 | |
| SCHEMBL50560 | 0.89 | — | — | |
| SCHEMBL6934486 | 0.83 | CES1 (0.47) | TSHRFAAHCES1THRBCES2 | |
| SCHEMBL6934662 | 0.83 | CES1 (0.47) | TSHRFAAHCES1THRBCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 733 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2202851-A | — | — | None | — | — | JP | disclosed |
| JP-4360851-A | — | — | None | — | — | JP | disclosed |
| JP-9309864-A | — | — | None | — | — | JP | disclosed |
| US-12031079-B2 | Polymerisable LC medium and polymer film with flat optical dispersion | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| US-11999717-B2 | Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| EP-4015598-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-05-22 | — | — | EP | disclosed |
| EP-3704176-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2024-05-15 | — | — | EP | disclosed |
| US-11958819-B2 | Compounds for optically active devices | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| EP-3794650-B1 | ORGANIC SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2024-03-13 | — | — | EP | disclosed |
| EP-3994234-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| US-5190686-A | LIQUID-CRYSTALLINE COPOLYMER | IDEMITSU KOSAN CO., LTD. (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0518636-A1 | Liquid crystal compounds and compositions | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1992-12-16 | — | — | EP | disclosed |
| JP-H04360851-A | CARBOXYLIC ACID ESTER COMPOUND AND LIQUID CRYSTAL COMPOUND | MITSUI PETROCHEM IND LTD | 1992-12-14 | — | — | JP | disclosed |
| EP-0517498-A1 | Liquid crystal compounds and compositions | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1992-12-09 | — | — | EP | disclosed |
| EP-0500210-A2 | Liquid crystal compounds and compositions | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-26 | — | — | EP | disclosed |
| EP-0465344-A1 | Liquid crystal compounds | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1992-01-08 | — | — | EP | disclosed |
| EP-0445037-A2 | Liquid crystal compound | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1991-09-04 | — | — | EP | disclosed |
| EP-0409634-A2 | Liquid crystal compounds and optically active compounds | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
| JP-H02202851-A | OPTICALLY ACTIVE COMPOUND, FERROELECTRIC LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME AND LIQUID CRYSTAL ELEMENT THEREOF | SHARP CORP | 1990-08-10 | — | — | JP | disclosed |
| EP-0355772-A2 | Liquid-crystalline copolymer | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958819-B2 | Compounds for optically active devices | PDE6C, ALDH1A2, PDE6A | TSHR 3898/4885FAAH 936/4885CES1 2051/4885 |
| US-11999717-B2 | Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof | LPAR3, LPAR1, LPAR2 | TSHR 196/4885FAAH 182/4885CES1 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.